In view of the role of lovastatin in sensitizing glioblastoma cell lines to TRAIL-induced apoptosis in vitro as well as in specifically inducing DR5 expression in vivo, we next tested whether lovastatin could enhance the efficacy of TRIAL on subcutaneous brain tumor in mice models. The gene discussed is TNFRSF10B; the disease is glioblastoma.